These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27755932)

  • 21. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging.
    Ohata S; Shimada T; Shimizu H; Murakami Y; Matsuno Y
    J Rheumatol; 2002 Apr; 29(4):861-2. PubMed ID: 11950039
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.
    Tien RD; Brasch RC; Jackson DE; Dillon WP
    Radiology; 1989 Sep; 172(3):791-2. PubMed ID: 2772189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proton spin tomography in meniscus diagnosis].
    Engel A; Kramer J; Nehrer S
    Orthopade; 1994 Apr; 23(2):112-6. PubMed ID: 8190502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter regarding Morsbach et al. "Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy".
    Ma H; Wang Y; Wang Y; Shi L; Zhang J; Wen Z; Chen L; Wang Z; Shi Y; Sun C; Pan Y; Liu J; Xie H; Yang J
    Int J Cardiol; 2018 Apr; 256():35. PubMed ID: 29395363
    [No Abstract]   [Full Text] [Related]  

  • 28. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The magnetic resonance assessment of craniofacial fibrous dysplasia. The completion of the study with gadolinium administration and magnetic resonance angiography].
    Di Girolamo M; Scipioni A; Laghi A; Corsetti A; Ferone E; Pavone P; Passariello R
    Radiol Med; 1996 Mar; 91(3):313-6. PubMed ID: 8628950
    [No Abstract]   [Full Text] [Related]  

  • 30. Twitter and Gadolinium Retention: Patient-Reported Perceptions of Gadolinium-Based Contrast Agents.
    Huneault L; Davenport MS; Verma R; Walker D; Schieda N
    J Am Coll Radiol; 2020 Oct; 17(10):1355-1358. PubMed ID: 32822645
    [No Abstract]   [Full Text] [Related]  

  • 31. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium-DTPA-enhanced magnetic resonance scanning in cerebellopontine angle tumors.
    Wayman JW; Dutcher PO; Manzione JV; Nelson CN; Kido DK
    Laryngoscope; 1989 Nov; 99(11):1167-70. PubMed ID: 2811558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report on the ISMRM-ESMRMB 2022 hot topic debate on the future of gadolinium as a contrast agent.
    Quattrocchi CC; Agarwal N; Taso M; Dekkers IA
    MAGMA; 2022 Oct; 35(5):707-710. PubMed ID: 35767161
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gadolinium-DTPA tolerance and clinical safety].
    Niendorf HP; Brasch RC
    Rontgenpraxis; 1997 Dec; 50(12):354-63. PubMed ID: 9492559
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperintense Dentate Nuclei at Precontrast T1-weighted MRI: Gadolinium Deposition or Brain Irradiation?
    Adin ME; Yousem DM
    Radiology; 2018 Aug; 288(2):632-633. PubMed ID: 29916780
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spin echo and inversion recovery sequences for gadolinium-DTPA enhanced magnetic resonance imaging of intracranial tumors.
    Laniado M; Niendorf HP; Schörner W; Felix R
    Acta Radiol Suppl; 1986; 369():469-71. PubMed ID: 2980530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxometry of magnetic resonance imaging contrast agents.
    Koenig SH; Brown RD
    Magn Reson Annu; 1987; ():263-86. PubMed ID: 3079341
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
    Kaltenborn H; Schadmand S; Beck T; Thelen M
    Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.